Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

Thursday’s trading has closed, but THRX is being traded in the after-hours session. After-Hours quote »
13.82
Delayed Data
As of 3:59pm ET
 +0.26 / +1.92%
Today’s Change
10.58
Today|||52-Week Range
23.84
-2.33%
Year-to-Date

Today’s Trading

Previous close13.56
Today’s open13.71
Day’s range13.37 - 13.97
Volume419,748
Average volume (3 months)567,138
Market cap$1.6B
Dividend yield7.24%
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+87.60%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.05+0.45%
MNKDMannkind Corp+0.26+7.12%
ALDRAlder Biopharmaceuti...+0.28+0.73%
INSMInsmed Inc+0.92+3.80%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers